Drugs / Alutard SQ timothy
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT06061848 Comparator | Feb 2023 → Dec 2030 expected | seasonal allergic rhinitis | Lars Olaf Cardell | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Alutard SQ timothy | “0,1 mL of Alutard SQ timothy, ALK Nordic, 10 000 SQ-U/mL as three intralymphatic injections” NCT06061848 ↗ |
| Route | Other | “as three intralymphatic injections” NCT06061848 ↗ |